MetaCap

Carlsmed (CARL) vs Phreesia (PHR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Carlsmed (CARL) has outperformed Phreesia (PHR) over the past year, gaining 5.8% versus a loss of 55.1%. Phreesia is the larger company by market cap ($655.2 million vs $380.3 million), about 1.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CARL+5.81%PHR-55.15%
+30%-20%-70%
Oct 7, 20251 yearOct 7, 2026
CARL-0.83%PHR-60.57%
+23%-25%-74%
Jul 21, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CARL versus PHR key metrics
MetricCARLPHR
Share price$13.93$10.56
Market cap$380.33M$655.16M
1-day change-3.13%+0.52%
YTD return+16.44%-37.94%
1-year return+5.81%-55.15%
5-year return—-83.51%
P/E ratio (TTM)—62.09
Forward P/E—6.67
EPS (TTM)$-1.08$0.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$17.23$24.25
52-week low$8.50$7.77
Distance from 52-week high-19.15%-56.47%
Analyst consensusstrong_buybuy
Avg. price target upside+37.83%+33.30%
Average volume125.43K741.28K
Shares outstanding27.30M62.07M
Employees1271,789
SectorHealth CareConsumer Discretionary
IndustryMedical/Dental InstrumentsBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CARL has outperformed PHR by 61.0 percentage points over the past year.
  • The two companies sit in different sectors: Carlsmed in Health Care and Phreesia in Consumer Discretionary.

About Carlsmed

CARL stock →

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Health Care · Medical/Dental Instruments · 127 employees

About Phreesia

PHR stock →

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Consumer Discretionary · Business Services · 1,789 employees

CARL vs PHR FAQ

Which is bigger, Carlsmed or Phreesia?

Phreesia (PHR) is larger, with a market capitalization of $655.16M compared with $380.33M for Carlsmed (CARL).

Which stock has performed better over the past year, CARL or PHR?

CARL returned +5.81% over the past 12 months, compared with -55.15% for PHR (price return, excluding dividends). Past performance does not predict future results.

Are Carlsmed and Phreesia in the same industry?

No. Carlsmed is in the Health Care sector, while Phreesia is in Consumer Discretionary.

More comparisons